Stefan Rose‐John
Impact in
- Immunology top 0.02%
- Immune Response and Inflammation
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Toxin Mechanisms and Immunotoxins
- Oncology top 0.02%
- Cytokine Signaling Pathways and Interactions
Papers in
- Oncology 314
- Cytokine Signaling Pathways and Interactions 233
- HER2/EGFR in Cancer Research 46
- Immunology 262
- Immune Response and Inflammation 67
- Immune Cell Function and Interaction 58
- Toxin Mechanisms and Immunotoxins 44
- Co-authors
- Jürgen Scheller (102 shared papers)Athena Chalaris (43 shared papers)Dirk Schmidt‐Arras (22 shared papers)Christoph Garbers (60 shared papers)Simon A. Jones (26 shared papers)Peter C. Heinrich (33 shared papers)Joachim Grötzinger (58 shared papers)Jürgen Müllberg (29 shared papers)
- Journals
- The Journal of Immunology (35 papers)Journal of Biological Chemistry (34 papers)FEBS Letters (19 papers)Cytokine (17 papers)Blood (15 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Stefan Rose‐John
559 papers receiving 47.8k citations
Stefan Rose‐John's Hit Papers
Peers
Comparison fields: 5 of 166
- Immunology 16.5k
- Oncology 16.2k
- Immunology and Allergy 2.2k
- Biological Psychiatry 872
- Cancer Research 4.3k
Countries citing papers authored by Stefan Rose‐John
This map shows the geographic impact of Stefan Rose‐John's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Rose‐John with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Rose‐John more than expected).
Fields of papers citing papers by Stefan Rose‐John
This network shows the impact of papers produced by Stefan Rose‐John. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Rose‐John. The network helps show where Stefan Rose‐John may publish in the future.
Co-authors
The 25 scholars most cited alongside Stefan Rose‐John, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 563 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The pro- and anti-inflammatory properties of the cytokine interleukin-6 Hit paper breakdown → | 2011 | 2535 |
| 2 | IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer Hit paper breakdown → | 2009 | 1763 |
| 3 | IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6 Hit paper breakdown → | 2012 | 816 |
| 4 | Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer Hit paper breakdown → | 2011 | 682 |
| 5 | IL-6 and Its Soluble Receptor Orchestrate a Temporal Switch in the Pattern of Leukocyte Recruitment Seen during Acute Inflammation Hit paper breakdown → | 2001 | 672 |
| 6 | IL-6 pathway in the liver: From physiopathology to therapy Hit paper breakdown → | 2016 | 668 |
| 7 | Soluble receptors for cytokines and growth factors: generation and biological function Hit paper breakdown → | 1994 | 654 |
| 8 | The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion Hit paper breakdown → | 2003 | 594 |
| 9 | TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling Hit paper breakdown → | 2004 | 594 |
| 10 | Interleukin-6 Family Cytokines Hit paper breakdown → | 2017 | 573 |
| 11 | A Switch from White to Brown Fat Increases Energy Expenditure in Cancer-Associated Cachexia Hit paper breakdown → | 2014 | 570 |
| 12 | Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer Hit paper breakdown → | 2006 | 535 |
| 13 | Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling Hit paper breakdown → | 2011 | 532 |
| 14 | Soluble gp130 is the natural inhibitor of soluble interleukin‐6 receptor transsignaling responses Hit paper breakdown → | 2001 | 531 |
| 15 | Interleukin-6 and its receptors: A highly regulated and dynamic system Hit paper breakdown → | 2014 | 478 |
| 16 | Interleukin-6: designing specific therapeutics for a complex cytokine Hit paper breakdown → | 2018 | 471 |
| 17 | 1997 | 449 | |
| 18 | 1993 | 441 | |
| 19 | 2011 | 428 | |
| 20 | 2003 | 419 |
About Stefan Rose‐John
Stefan Rose‐John is a scholar working on Oncology, Immunology, Molecular Biology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 563 papers that have together received 48.5k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (233 papers), Immune Response and Inflammation (67 papers), Immune Cell Function and Interaction (58 papers), NF-κB Signaling Pathways (51 papers), Monoclonal and Polyclonal Antibodies Research (50 papers), Cell Adhesion Molecules Research (48 papers), HER2/EGFR in Cancer Research (46 papers) and Toxin Mechanisms and Immunotoxins (44 papers). The work is most often cited by research in Immunology (16.5k citations), Oncology (16.2k citations), Immunology and Allergy (2.2k citations), Biological Psychiatry (872 citations) and Cancer Research (4.3k citations). Stefan Rose‐John has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Jürgen Scheller, Athena Chalaris, Dirk Schmidt‐Arras, Christoph Garbers, Simon A. Jones, Peter C. Heinrich, Joachim Grötzinger, Jürgen Müllberg, Heidi Schooltink and Georg H. Waetzig. Their work appears in journals such as The Journal of Immunology, Journal of Biological Chemistry, FEBS Letters, Cytokine and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.